News
GoodRx reports on identifying real Wegovy pens, which come in five colors and lack dose selectors. Counterfeits pose health ...
1d
The Print on MSNIndia sees 20k bariatric surgeries a year. But blockbusters Mounjaro, Wegovy are shaking up obesity arena
India's anti-obesity drug market is valued at Rs 3,000-3,500 crore and is projected to grow nearly eightfold to Rs 25,000 ...
A federal court ruled in Mylan's favor, finding no infringement of Novo's patent tied to Wegovy, rejecting direct, ...
After inking a related patent settlement last year, Viatris has cleared another obstacle in its quest to launch generic ...
A young woman details her experience with the newly available weight loss medication.
Weight loss injections could be key to controlling a chronic condition in thousands of Brits, new research suggests ...
Explore more
"My scene was supposed to be funny, and it got nothing in the f---ing Chinese Theatre," the comedian says while discussing ...
3d
Money Talks News on MSNYour Wegovy Access Just Changed: What Patients Need to Know Now
Novo Nordisk just pulled Wegovy from a major telehealth platform over safety concerns about knockoff versions. Here's what ...
In a study on people with obesity and asthma, researchers saw “significant” improvements in the asthma scores of people who ...
2d
Verywell Health on MSNWhat Happens to Your Body When You Stop Taking Ozempic
Many people stop taking GLP-1 drugs like Ozempic within a year, but doing so often leads to weight regain. Here's what to ...
People who stop taking GLP-1 medications like Ozempic and Wegovy started to regain weight in a short amount of time, ...
3don MSN
India's Dr Reddy's plans to launch generic obesity drugs in 87 countries next year, CEO says
Dr Reddy's Laboratories plans to launch a cheaper copycat version of Novo Nordisk's blockbuster weight-loss drug Wegovy in 87 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results